iShares US Pharmaceuticals ETF
IHE
IHE
103 hedge funds and large institutions have $358M invested in iShares US Pharmaceuticals ETF in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
+1
Holders Change %
+0.98%
% of All Funds
2.7%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
16
Increased
29
Reduced
38
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Goldman Sachs
New York
|
$40.4M |
2 |
2
LPL Financial
San Diego,
California
|
$22.1M |
3 |
EM
3
EnTrustPermal Management
New York
|
$6.42M |
4 |
4
Morgan Stanley
New York
|
$48.5M |
5 |
5
UBS Group
Zurich,
Switzerland
|
$11.5M |